Citation Impact
Citing Papers
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
2018
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
2014 Standout
Catheter Ablation for the Treatment of Electrical Storm in Patients With Implantable Cardioverter-Defibrillators
2008
What influences recruitment to randomised controlled trials? A review of trials funded by two UK funding agencies
2006 Standout
Electrical isolation of a substrate after myocardial infarction: a novel ablation strategy for unmappable ventricular tachycardias--feasibility and clinical outcome
2014
Catheter ablation of electrical storm
2011
Chronobiology, drug delivery, and chronotherapeutics
2007
Central Challenges Facing the National Clinical Research Enterprise
2003
Perceptions of equipoise are crucial to trial participation: a qualitative study of men in the ProtecT study
2003
Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies
2006 Standout
Improved Survival Associated with Prophylactic Implantable Defibrillators in Elderly Patients with Prior Myocardial Infarction and Depressed Ventricular Function: A MADIT‐II Substudy
2007
HRS Expert Consensus Statement on the Diagnosis and Management of Arrhythmias Associated With Cardiac Sarcoidosis
2014 Standout
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance
2012
Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events
2009 Standout
The REDCap consortium: Building an international community of software platform partners
2019 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure
2005 Standout
Heart Failure with Preserved and Reduced Ejection Fraction in Hemodialysis Patients: Prevalence, Disease Prediction and Prognosis
2017 Standout
Global incidences of out-of-hospital cardiac arrest and survival rates: Systematic review of 67 prospective studies
2010 Standout
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Trends in treated ventricular fibrillation out-of-hospital cardiac arrest: A 17-year population-based study
2004
The Meaning of Translational Research and Why It Matters
2008 Standout
Randomised trial of home-based psychosocial nursing intervention for patients recovering from myocardial infarction
1997
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
The impact of negative emotions on prognosis following myocardial infarction: Is it more than depression?
1995
Preliminary structure and predictive value of attenuated negative symptoms in 22q11.2 deletion syndrome
2012
NON‐CORONARY HEART DISEASE IN DIALYSIS PATIENTS: Sudden Cardiac Death and Dialysis Patients
2008
Evidence rather than costs must guide use of the implantable cardioverter defibrillator
2000
Participation in Research and Access to Experimental Treatments by HIV-Infected Patients
2002
Polymeric micelles for drug targeting
2007
Implementation Research in Mental Health Services: an Emerging Science with Conceptual, Methodological, and Training challenges
2008 Standout
Depression and health-care costs during the first year following myocardial infarction
2000
Comparison of Baseline Characteristics, Management and Outcome of Patients With Non–ST-Segment Elevation Acute Coronary Syndrome in Versus Not in Clinical Trials
2010
Employment, work disability, and work days lost in patients with ankylosing spondylitis: a cross sectional study of Dutch patients
2001
EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: Developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA)
2009
The Importance of Race and Ethnic Background in Biomedical Research and Clinical Practice
2003 Standout
Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures
2004 Standout
Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial
2002 Standout
Task Force on Sudden Cardiac Death of the European Society of Cardiology
2001
Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials
2000
The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo
2012 Standout
Understanding implantable cardioverter defibrillator shocks and storms: Medical and psychosocial considerations for research and clinical care
2003
Effectiveness of implantable defibrillators for preventing arrhythmic events and death
2003
Sudden Death Due to Cardiac Arrhythmias
2001
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)
2005 Standout
Conflicts of Interest in Cardiovascular Clinical Practice Guidelines
2011 Standout
Catheter Ablation of Electrical Storm in a Collaborative Hospital Network
2011
Depression and 1-Year Prognosis in Unstable Angina
2000
Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial
2010
22q11.2 deletion syndrome
2015 Standout
Knowledge translation of research findings
2012 Standout
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
2013 Standout
Are Racial and Ethnic Minorities Less Willing to Participate in Health Research?
2005
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
2005 Standout
Threats to Applicability of Randomised Trials: Exclusions and Selective Participation
1999
Limitations of Ejection Fraction for Prediction of Sudden Death Risk in Patients With Coronary Artery Disease
2007
Management of patients receiving implantable cardiac defibrillator shocks: Recommendations for acute and long-term patient management
2010
Long-Term Clinical Course of Patients After Termination of Ventricular Tachyarrhythmia by an Implanted Defibrillator
2004
Implantable Cardioverter Defibrillator Therapy
2000
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
EFFECTIVE RECRUITMENT AND RETENTION OF MINORITY RESEARCH PARTICIPANTS
2005 Standout
Cost-Effectiveness of the Implantable Cardioverter-Defibrillator
2001
EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias
2009
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease
2008 Standout
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Mapping and Ablation of Idiopathic Ventricular Fibrillation
2002
Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy
2020 Standout
Depression and Coronary Heart Disease
2008 Standout
The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes
2006
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Social Relationships and Health: A Flashpoint for Health Policy
2010 Standout
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Quality of Life in the Antiarrhythmics Versus Implantable Defibrillators Trial
2002
Cost-Effectiveness of the Implantable Cardioverter-Defibrillator Versus Antiarrhythmic Drugs in Survivors of Serious Ventricular Tachyarrhythmias
2002
Impact of Psychological Factors on the Pathogenesis of Cardiovascular Disease and Implications for Therapy
1999 Standout
Mapping the impact of patient and public involvement on health and social care research: a systematic review
2012 Standout
Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators
2009
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Risky families: Family social environments and the mental and physical health of offspring.
2002 Standout
Gender, Depression, and One-Year Prognosis After Myocardial Infarction
1999
A Systematic Review of Barriers and Facilitators to Minority Research Participation Among African Americans, Latinos, Asian Americans, and Pacific Islanders
2013 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Administration of substances to laboratory animals: routes of administration and factors to consider.
2011 Standout
Irrigated Radiofrequency Catheter Ablation Guided by Electroanatomic Mapping for Recurrent Ventricular Tachycardia After Myocardial Infarction
2008
Core/Shell Nanoparticles: Classes, Properties, Synthesis Mechanisms, Characterization, and Applications
2011 Standout
Consensus Statement: Consensus Statement of the European Heart Rhythm Association: Updated Recommendations for Driving by Patients with Implantable Cardioverter Defibrillators
2010
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Racial-Ethnic Disparities in Stroke Care: The American Experience
2011 Standout
Social Relationships and Health.
2004 Standout
2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2012
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
2017
Consumer involvement in consent document development: a multicenter cluster randomized trial to assess study participants' understanding
2006
Works of Scott Lancaster being referenced
Clinical trial enrollers vs. nonenrollers: The Cardiac Arrhythmia Suppression Trial (CAST) Recruitment and Enrollment Assessment in Clinical Trials (REACT) project
1996
Determinants of outcome in patients with sustained ventricular tachyarrhythmias: The Antiarrhythmics Versus Implantable Defibrillators (AVID) study registry
2000
Relation of Circadian Ventricular Ectopic Activity to Cardiac Mortality**This study was supported by contracts with the National Heart, Lung, and Blood Institute, Department of Health and Human Services, Bethesda, Maryland.
1996
Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias
1999
In-hospital versus out-of-hospital presentation of life-threatening ventricular arrhythmias predicts survival
1999
Association between changes on the Negative Symptom Assessment scale (NSA-16) and measures of functional outcome in schizophrenia
2009
Baseline factors predicting early resumption of driving after life-threatening arrhythmias in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial
2001
Asenapine in the Treatment of Negative Symptoms of Schizophrenia: Clinical Trial Design and Rationale
2025
“Stable” Ventricular Tachycardia Is Not a Benign Rhythm
2001
Electrical Storm Presages Nonsudden Death
2001